Therapeutic Solutions International Enters into Multi-Million Dollar Master Sales Agreement with Publicly Traded iBrands
January 21 2020 - 9:00AM
InvestorsHub NewsWire
Therapeutic Solutions International Enters
into Multi-Million Dollar Master
Sales Agreement with Publicly Traded iBrands
Corporation
Proprietary Nano Particle
Cannabidiol based products to be sold through iBrands
Farms
OCEANSIDE, CA --
January 21, 2020 -- InvestorsHub NewsWire
-- Therapeutics
Solutions International, Inc., (OTC
Markets:
TSOI)
announces today the
signing
of a Master Sales
Agreement with iBrands
Corporation to distribute the
nutraceutical line of products developed by TSOI
for sales
through its iBrands Farms subsidiary.
Products to be
included in the Master Sales Agreement currently consists of
NanoStilbene,
NanoPSA, Nano Plus, Nano Cannabidiol, and
ProJuvenol.
Future products will be added to Master List as
commercialized.
"Today's sales
Agreement with iBrands will deliver yet another revenue stream to
TSOI as they market and sell our Cannabidiol based products through
their iBrands Farms
subsidiary" said Timothy Dixon,
President and CEO of TSOI. "Cannabidiol (also
known as CBD) is a phytocannabinoid derived from the cannabis
species, and
is devoid
of psychoactive activity, but at the same
time has analgesic,
anti-inflammatory, antineoplastic and chemo
preventive activities."
Nano Cannabidiol is a
proprietary formulation of nano particle cannabidiol isolate in the
range of 75 nanometers at a concentration of 200mg per
milliliter. Nano Cannabidiol has
been engineered to cross the brain-blood-barrier as both an oral
formulation and
as
a
intranasal
delivery.
"We are excited to be
able to bring these unique nutraceutical products into our
line-up of CBD-related offerings. There is nothing else like
them in the market and the science behind them is first rate," said
Hugh Kelso, CEO of iBrands Corporation. "We are working very
close with TSOI to get the new products packaged, labeled, and
delivered to us just as soon as physically possible" added Mr.
Kelso.
About
Therapeutic Solutions International, Inc.
Therapeutic Solutions
International is focused on immune modulation for the treatment of
several specific diseases. Immune modulation refers to the ability
to upregulate (make more active) or downregulate (make less active)
one's immune system. The Company's corporate website is at
www.therapeuticsolutionsint.com
and our
e-commerce is at www.youcanordernow.com and for additional
info on NanoStilbene visit www.nanostilbene.com.
About iBrands
Corporation
iBrands
Corporation, Inc. is a holding and branding company that acquires
and operates niche market brands that have unique market positions
within sectors that demonstrate return on investment potential.
Business partnerships throughout the United States and Canada
provide our brands many markets to expand into and produce
consistently high growth rates for the next decade. The company can
be found at: http://www.ibrandsfarms.com and http://www.ibrandscorporation.com.
These statements have
not been evaluated by the Food and Drug Administration. These
products are not intended to diagnose, treat, cure, or prevent any
disease.
Safe
Harbor
Statement
This
release contains forward-looking statements that are based upon
current expectations or beliefs, as well as a number of assumptions
about future events. Although we believe that the expectations
reflected in the forward-looking statements and the assumptions
upon which they are based are reasonable, we can give no assurance
that such expectations and assumptions will prove to have been
correct. Forward-looking statements are generally identifiable by
the use of words like "may," "will," "should," "could," "expect,"
"anticipate," "estimate," "believe," "intend," or "project" or the
negative of these words or other variations on these words or
comparable terminology. The reader is cautioned not to put undue
reliance on these forward-looking statements, as these statements
are subject to numerous risk factors as set forth in our SEC
filings. To the extent that statements in this press release are
not strictly historical, including statements as to product launch
timing, revenue projections, business strategy, outlook,
objectives, future milestones, plans, intentions, goals, future
collaboration agreements, or otherwise as to future events, such
statements are forward-looking, and are made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act
of 1995. The forward-looking statements contained in this release
are subject to certain risks and uncertainties that could cause
actual results to differ materially from the statements
made.
Contact
Information:
Therapeutic Solutions (PK) (USOTC:TSOI)
Historical Stock Chart
From Aug 2024 to Sep 2024
Therapeutic Solutions (PK) (USOTC:TSOI)
Historical Stock Chart
From Sep 2023 to Sep 2024